Personalized Vagus Nerve Stimulation to Help You Relax, Think, and Learn

Relax. Think. Learn.

REVAI is developing a software application and AI/ML-powered Vagus Nerve Stimulation (VNS) platform that helps transfer cutting-edge brain research into real-world benefits for end users.

REVAI & TWS

True Wireless Stereo (TWS) earbuds offer precise anatomical fit for REVAI VNS sensor technology and a proven form factor used by millions of consumers.

REVAI’s solution consists of:

Head with gear icon AI/ML Platform
Phone Icon Mobile and Computer  Application Software
Earbud Icon TWS Earbuds

APPLICATIONS

VNS is effective for relaxation and cognition applications.

Illustration of open book
Learning

VNS induces positive short- and long-term effects on memory performance.

Illustration of 2 trees on a hill
Wellness

VNS activates the parasympathetic nervous system that reduces anxiety.

Green arrows pointing up
Future Indications

VNS for multiple indications is actively being studied by a global research community.

TECHNOLOGY

AI-Powered Vagus Nerve Stimulation

Transcutaneous auricular vagus nerve stimulation (taVNS) involves electrical stimulation of the vagus nerve at the cymba concha of the outer ear. This technique has proven to be a robust approach to neuromodulation, affecting aspects of cognition and well-being. 

Our patented solution leverages an AI/ML platform to personalize user experience through any REVAI-enabled TWS earbuds.

RESEARCH SNAPSHOT

Neural networks and the anti-inflammatory effect of transcutaneous auricular vagus nerve stimulation in depression

Non-invasive peripheral nerve stimulation selectively enhances speech category learning in adults

Auricular Transcutaneous Vagus Nerve Stimulation (tVNS) Affects Mood and Anxiety During second Language Learning

Transcutaneous auricular vagus nerve stimulation enhances learning of novel letter-sound relationships in adults

Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial

Promoting long-term inhibition of human fear responses by non-invasive transcutaneous vagus nerve stimulation during extinction training

ABOUT US

REVAI is backed by TandemLaunch, one of Canada’s most successful pre-seed tech incubators. Our management team includes two Ph.D. scientists and an experienced business leader who sold his last venture to Google. We are collaborating with researchers at UC San Diego, McGill University, Université de Montréal, and the University of Toronto. Our advisors include prominent researchers and industry executives from leading wellness and learning companies.

Headshot of Perry Teevens
Perry Teevens

CEO and Co-Founder

Headshot of Shawn Maloney
Shawn Maloney, PhD

CSO and Co-Founder

Headshot of Neha Bhutani
Neha Bhutani, PhD

CTO and Co-Founder

Headshot of Kevin (Sherry) Xu
Kexin (Sherry) Xu

Embedded Systems Engineer

Headshot of Simon St-Hilaire
Simon St-Hilaire

Senior Director of Engineering

Logos of McGill University and Université de Montréal
Logos of UC San Diego and University of Toronto

REVAI Logo

RTAI Inc.

CONTACT US     info@revai.com

780v. Brewster, Montréal, QC, H4C 2K1